Iván González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:
“Tumor agnostic therapies are redefining precision oncology, making comprehensive genomic profiling and biomarker driven decisions increasingly important. The challenge: translating molecular findings into meaningful clinical benefit.
Watch here the complete webinar.”
You can also read:
Comprehensive Genomic Profiling in GI Oncology: Real-World Impact and Challenges
